Skip to main content
SpringerLink
Log in

Antihypertensive therapy in pregnancy

Current Hypertension Reports Aims and scope Submit manuscript

Cite this article

Abstract

Human pregnancy, normally characterized by systemic vasodilation and modest hypotension, can be complicated by underlying maternal hypertension and several unique hypertensive disorders, including pre-eclampsia. Although well-designed and adequately powered clinical trials are critically needed, there have been several recent meta-analyses of this large literature, along with consensus statements and treatment guidelines from three distinct multidisciplinary groups of clinicians and investigators. In this paper we review recent analyses and guidelines, advising on our current approach to antihypertensive therapy in pregnant women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Redman CWG, Beilin LJ, Bonnar J, Ounsted MK: Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet 1976, 2:753–756.

    Article  PubMed  CAS  Google Scholar 

  2. Lindheimer MD, Roberts JM, Cunningham FG: Chesley’ Hypertensive Disorders in Pregnancy, edn 2. Stamford: Appleton & Lange; 1999. This 654-page, multiauthored text provides the most comprehensive review available of cardiovascular physiology and pathophysiology in pregnancy, insights to the pathogenesis of pre-eclampsia, and critical review of strategies for the clinical management of these patients.

    Google Scholar 

  3. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. NIH Publication No. 00-3029, July 2000. Accessible at www.nhlbi.nih.gov/health/prof/heart/hbp_preg.htm This consensus statement, revised 10 years after its initial publication, provides useful guidelines for the evaluation and management of hypertensive gravidas.

  4. Brown MA, Hague WM, Higgins J, et al.: The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynecol 2000, 40:139–155. This consensus statement of the Australasian Society for the Study of Hypertension in Pregnancy provides useful guidelines with minor specific differences from the NHBPEP Working Group.

    CAS  Google Scholar 

  5. Rey E, LeLorier J, Burgess E, et al.: Report of the Canadian Hypertension Society consensus conference. 3. Pharmacologic treatment of hypertensive disorders in pregnancy. Can Med Assoc J 1997, 157:1245–1254. The Canadian Hypertension Society statement, based on a critical literature review, preceded publication of references 3 and 4, above. These three sets of clinical guidelines are in essential agreement, reflecting perhaps appropriate circumspection in the face of limited data.

    CAS  Google Scholar 

  6. Shear R, Leduc L, Rey E, Moutquin JM: Hypertension in pregnancy: new recommendations for management. Curr Hypertens Rep 1999, 1:529–539.

    PubMed  CAS  Google Scholar 

  7. Walker JJ: Pre-eclampsia. Lancet 2000, 356:1260–1265.

    Article  PubMed  CAS  Google Scholar 

  8. Sibai BM, Abdella TN, Anderson GD: Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983, 61:571–576.

    PubMed  CAS  Google Scholar 

  9. Sibai BM, Lindheimer MD, Hauth J, et al.: Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998, 339:667–671.

    Article  PubMed  CAS  Google Scholar 

  10. Rey E, Couturier A: The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol 1994, 171:410 416.

    PubMed  Google Scholar 

  11. Ferrer RL, Sibai BM, Mulrow CD, et al.: Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 2000, 96:849–860. This presents a summary of an evidence-based review conducted for the US Agency for Healthcare Research and Quality; the full report is available from their web site at http://www.ahcpr.gov/clinic/ evrptfiles.htm.

    Article  PubMed  CAS  Google Scholar 

  12. Magee LA, Ornstein MP, von Dadelszen P: Management of hypertension in pregnancy. BMJ 1999, 318:1332–1336. A thoughtful review with meta-analysis of recent relevant trials.

    PubMed  CAS  Google Scholar 

  13. Sibai BM: Treatment of hypertension in pregnant women. N Engl J Med 1996, 335:257–265. A thoughtful, selective review, including specific treatment guidelines, from one of the most prolific clinical investigators in the field.

    Article  PubMed  CAS  Google Scholar 

  14. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ: Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001, 2:CD002252. A new meta-analysis from the Cochrane library. First to raise the possibility of differences between classes of antihypertensive agents.

    PubMed  Google Scholar 

  15. Magee LA, Duley L: Oral beta blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2000, 4:CD002863. Largest meta-analysis of β-blocker use in pregnancy.

    PubMed  Google Scholar 

  16. Duley L, Henderson-Smart DJ: Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2000, 2:CD001449. Meta-analysis results are much in accord with latest guidelines from Canadian, Australasian, and US groups.

    PubMed  Google Scholar 

  17. Huisjes HJ, Hadders-Algra M, Touwen BC: Is clonidine a behavioural teratogen in the human? Early Hum Dev 1986, 14:43–48.

    Article  PubMed  CAS  Google Scholar 

  18. Reynolds B, Butters L, Evans J, et al.: First year of life after the use of atenolol in pregnancy associated hypertension. Arch Dis Child 1984, 59:1061–1063.

    PubMed  CAS  Google Scholar 

  19. Bortolus R, Ricci E, Chatenoud L, Parazzini F: Nifedipine administered in pregnancy: effect on the development of children at 18 months. Br J Obstet Gynaecol 2000, 107:792–794.

    CAS  Google Scholar 

  20. Cockburn J, Moar VA, Ounsted M, Redman CW: Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1982, 1:647–649.

    Article  PubMed  CAS  Google Scholar 

  21. von Dadelszen P, Ornstein MP, Bull SB, et al.: Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000, 355:87–92.

    Article  Google Scholar 

  22. August P, Lenz T, Ales KL, et al.: Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to development of superimposed preeclampsia. Am J Obstet Gynecol 1990, 163:1612–1621.

    PubMed  CAS  Google Scholar 

  23. Visser W, Wallenburg HCS: Central hemodynamic observations in untreated preeclamptic patients. Hypertension 1991, 17:1072–1077.

    PubMed  CAS  Google Scholar 

  24. Bosio PM, McKenna PJ, Conroy R, O’Herlihy C: Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol 1999, 94:978–984.

    Article  PubMed  CAS  Google Scholar 

  25. Easterling TR, Brateng D, Schmucker B, et al.: Prevention of preeclampsia: A randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 1999, 93:725–733.

    Article  PubMed  CAS  Google Scholar 

  26. Schobel HP, Fischer T, Heuszer K, et al.: Preeclampsia-a state of sympathetic overactivity. N Engl J Med 1996, 335:1480–1485.

    Article  PubMed  CAS  Google Scholar 

  27. August P, Mueller FB, Sealey JE, Edersheim TG: Role of renin-angiotensin system in blood pressure regulation in pregnancy. Lancet 1995, 345:896–897.

    Article  PubMed  CAS  Google Scholar 

  28. Wallukat G, Homuth V, Fischer T, et al.: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945–952.

    Article  PubMed  CAS  Google Scholar 

  29. Pryde PG, Sedman AB, Nugent CE, Barr MJr: Angiotensinconverting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993, 3:1575–1582.

    PubMed  CAS  Google Scholar 

  30. Buttar HS: An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development. Mol Cell Biochem 1997, 176:61–71.

    Article  PubMed  CAS  Google Scholar 

  31. Spence SG, Zacchei AG, Lee LL, et al.: Toxicokinetic analysis of losartan during gestation and lactation in the rat. Teratology 1996, 53:245–252.

    Article  PubMed  CAS  Google Scholar 

  32. Tomlinson AJ, Campbell J, Walker JJ, Morgan C: Malignant primary hypertension in pregnancy treated with lisinopril. Ann Pharmacother 2000, 34:180–182.

    Article  PubMed  CAS  Google Scholar 

  33. Easterling TR, Carr DB, Davis C, et al.: Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy. Obstet Gynecol 2000, 96:956–961.

    Article  PubMed  CAS  Google Scholar 

  34. Montan S, Anandakumar C, Arulkumaran S, et al.: Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993, 168:152–156.

    PubMed  CAS  Google Scholar 

  35. Butters L, Kennedy S, Rubin PC: Atenolol in essential hypertension during pregnancy. BMJ 1990, 301:587–589.

    PubMed  CAS  Google Scholar 

  36. Lip GY, Beevers M, Churchill D, et al.: Effect of atenolol on birthweight. Am J Cardiol 1997, 79:1436–1438.

    Article  PubMed  CAS  Google Scholar 

  37. Gallery EDM, Ross MR, Gyory AZ: Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa. BMJ 1985, 291:563–566.

    Article  PubMed  CAS  Google Scholar 

  38. Collins R, Yusuf S, Peto R: Overview of randomised trials of diuretics in pregnancy. BMJ 1985, 290:17–23.

    PubMed  CAS  Google Scholar 

  39. Bolte AC, van Geijn HP, Dekker GA: Pharmacological treatment of severe hypertension in pregnancy: the role of serotonin 2 receptor blockers. Eur J Obstet Gynecol Reprod Biol 2001, 95:22–36.

    Article  PubMed  CAS  Google Scholar 

  40. Steyn DW, Odendaal HJ: Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin. Obstet Gynecol Surv 2000, 55:582–589.

    Article  PubMed  CAS  Google Scholar 

  41. Visser W, Wallenburg HC: A comparison between the hemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe preeclampsia. J Hypertens 1995, 13:791–795.

    PubMed  CAS  Google Scholar 

  42. Gallery ED, Gyory AZ: Sublingual nifedipine in human pregnancy. Aust N Z J Med 1997, 27:538–542.

    PubMed  CAS  Google Scholar 

  43. van Harten J, Burggraaf K, Danhof M, et al.: Negligible sublingual absorption of nifedipine. Lancet 1987, 2:1363–1365.

    PubMed  Google Scholar 

  44. Fenakel K, Fenakel G, Appelman Z, et al.: Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991, 77:331–337.

    PubMed  CAS  Google Scholar 

  45. Blea CW, Barnard JM, Magness RR, et al.: Effect of nifedipine on fetal and maternal hemodynamics and blood gases in the pregnant ewe. Am J Obstet Gynecol 1997, 176:922–930.

    Article  PubMed  CAS  Google Scholar 

  46. Scardo JA, Vermillion ST, Hogg BB, Newman RB: Hemodynamic effects of oral nifedipine in preeclamptic hypertensive emergencies. Am J Obstet Gynecol 1996, 175:336–338.

    Article  PubMed  CAS  Google Scholar 

  47. Martinez-Abundis E, Gonzalez-Ortiz M, Hernandez-Salazar F, Huerta-J-Lucas MT: Sublingual isosorbide dinitrate in the acute control of hypertension in severe preeclampsia. Gynecol Obstet Invest 2000, 50:39–42.

    Article  PubMed  CAS  Google Scholar 

  48. Aya AG, Mangin R, Hoffet M, Eledjam JJ: Intravenous nicardipine for severe hypertension in preeclampsia-effects of treatment on mother and foetus. Intensive Care Med 1999, 25:1277.

    Article  PubMed  CAS  Google Scholar 

  49. Shoemaker CT, Meyers M: Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity. Am J Obstet Gynecol 1984, 149:171–173.

    PubMed  CAS  Google Scholar 

  50. Wasserstrum N: Nitroprusside in preeclampsia. Circulatory distress and paradoxical bradycardia. Hypertension 1991, 18:79–84.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Georgetown University Medical Center, 6PHC, 3800 Reservoir Road, 20007, Washington, DC, NW, USA

    Jason G. Umans MD, PhD, FACP

Authors
  1. Jason G. Umans MD, PhD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marshall D. Lindheimer MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Umans, J.G., Lindheimer, M.D. Antihypertensive therapy in pregnancy. Current Science Inc 3, 392–399 (2001). https://doi.org/10.1007/s11906-001-0056-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0056-0

Keywords

search

Navigation